Melanoma & Skin Cancer | Specialty

The OncLive Melanoma & Skin Cancer condition center page is a comprehensive resource for clinical news and expert insights on various types of skin cancers, including melanoma, basal cell carcinoma, and more. This section features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in melanoma and other skin cancers.

Dr. Luke on Challenges With Immunotherapy in Melanoma

December 20th 2016

Jason Luke, MD, an assistant professor of Medicine at the University of Chicago Medicine, discusses some of the challenges that oncologists may face when administering immunotherapy agents to patients with melanoma.

Stefani Spranger on Checkpoint Blockade Therapies in Melanoma

December 16th 2016

Stefani Spranger, PhD, postdoctoral fellow, Cancer Research Institute at The University of Chicago, discusses immune checkpoint blockade therapies that are currently being used to treat patients with melanoma.

Dr. Hamid on Promising Phase III Trials in Melanoma

December 16th 2016

Omid Hamid, MD, chief, Translational Research and Immunotherapy, director, Melanoma Therapeutics, The Angeles Clinic and Research Institute, discusses 2 exciting, ongoing phase III randomized trials in melanoma.

The Future Management of Melanoma

December 9th 2016

Remaining Research Questions in Advanced Melanoma

December 9th 2016

T-VEC Data in the Neoadjuvant Setting in Melanoma

December 9th 2016

Neoadjuvant Trials in High-risk Melanoma

December 9th 2016

Alternative Adjuvant Approaches in Stage III Melanoma

December 9th 2016

Adjuvant Therapy Options in Advanced Melanoma

December 9th 2016

Case 3: Post-Surgical Recurrent Melanoma

December 9th 2016

Melanoma: Nuances of BRAF/MEK Combinations in the Front line

December 9th 2016

Sequencing Decisions and Multidisciplinary Care in Metastatic Melanoma

December 9th 2016

Patient Selection in Melanoma: Immunotherapy vs Targeted Therapy

December 9th 2016

Achieving Durable Responses in Advanced Melanoma

December 9th 2016

Case 2: Frontline Decisions in Stage IV BRAF-mutant Melanoma

December 9th 2016

Immunotherapy in Melanoma: Managing Toxicities

December 9th 2016

Melanoma: Helping Patients Understand Immunotherapy

December 9th 2016

Case I: Newly Diagnosed BRAF Wild Type Advanced Melanoma

December 9th 2016

The Current Understanding of Biomarkers in Melanoma

December 9th 2016

Dr. Long on Treating Melanoma With Dabrafenib Plus Trametinib

November 17th 2016

Georgina V. Long, BSc, PhD, MBBS, chair of Melanoma Medical Oncology and Translational Research at the Melanoma Institute of Australia (MIA) and Royal North Shore Hospital, University of Australia, discusses the patients with melanoma who respond best to the combination of dabrafenib plus trametinib.